摘要
目的研究探索医疗机构在2019年新《药品管理法》下药物警戒工作面临的挑战。方法采用文献分析、综合分析的方法进行论述性分析。结果医疗机构发现和研判药品安全性风险隐患能力不足,开展药物警戒工作的热情不高,工作人员数量不够。结论建立完备的医院药物警戒体系,加强相关工作的业务培训,广泛发挥社会力量,共同促进医疗机构开展药物警戒工作。
Objective To explore the challenges to pharmacovigilance by medical institutions under the new Drug Administration Law.Methods Literature analysis and comprehensive analysis were conducted for the discussion.Results Medical institutions lacked the ability to find and evaluate the potential risks to drug safety,showed poor initiative for pharmacovigilance,and were understaffed.Conclusion It is recommended that a complete hospital pharmacovigilance system be established,related training be improved,and social forces be given full play to in order to promote pharmacovigilance by medical institutions.
作者
冯亚楠
刘欣欣
李永辉
王芳
郭瑞锋
FENG Yanan;LIU Xinxin;LI Yonghui;WANG Fang;GUO Ruifeng(Center for Drug Monitoring and Evaluation of Hebei,Shijiazhuang Hebei 050090)
出处
《中国药物警戒》
2020年第9期572-573,582,共3页
Chinese Journal of Pharmacovigilance
关键词
药品管理法
药物警戒
医疗机构
挑战
Drug Administration Law
pharmacovigilance
medical institutions
challenge